Partnering and Licensing
Ology Bioservices has several Vaccine Programs available for partnering and/or licensing. These include Ross River (Phase III), Chikungunya, Pandemic and Seasonal Flu vaccines, Yellow Fever (MVA), Typhoid, West Nile and Norovirus. Please contact us for further information.
Ology Bio’s Vero Cell Platform – Veroplex™ (DMF 10336, Master and Working Cell Banks)
Vero Cells
Optimized for production of vaccines, fully characterized, and successful track record:
Vero cell vaccines are licensed in the EU as well as in the US, Australia, New Zealand, and Brazil
Adapted to serum-free media
Suitable for production of all types of viral vaccines:
- inactivated whole virus
- live-attenuated
- split/subunit
References:
Barrett et al, Expert Rev. Vaccines 8(5), 607-618 (2009).
Barrett et al, Expert Rev. Vaccines 16(9), 883-894 (2017).
Ology Bio’s Delivery Platform for Vaccines and Biological Therapeutics – GelSite®
(DMF 18741)
Suitable for multiple modes and routes of administration:
- Unique in-situ gelation function and cGMP manufacturing process
Three delivery platform technologies based on GelSite polymer have been developed:
- GelVac™ powder for nasal delivery of vaccines and protein/peptide therapeutics
- Injectable formulation for protein/peptide therapeutics
- Depot adjuvant for immunoenhancing and antigen sparing